BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ex-Home Diagnostics, Inc. CEO Avoids Prison for Insider Trading


12/18/2012 8:35:31 AM

George Holley, former chief executive officer and chairman of Home Diagnostics Inc., avoided prison when he was sentenced to three years of probation for insider trading. Holley, 72, was sentenced today in federal court in Trenton, New Jersey, where he pleaded guilty on Aug. 8 to two counts of securities fraud in his trial’s eighth day. Holley faced between 33 and 41 months in prison under advisory sentencing guidelines, according to his attorney, Kevin Marino. U.S. District Judge Joel Pisano also fined him $260,000. Pisano had dismissed some of the charges at trial after prosecutors rested their case, Marino said. Holley admitted tipping his cousin and a friend that Osaka, Japan-based Nipro Corp. (8086), a maker of medical equipment, would buy his company. Prosecutors said he told them to buy Home Diagnostics stock three weeks before the merger was announced. “We always felt that a probationary sentence was appropriate in this case, and we are very gratified that that sentence was ultimately imposed,” Marino said. “Mr. Holley has lived an extraordinary life marked by generosity of spirit and philanthropy. He regrets his foolish mistake.” Matthew Reilly, a spokesman for U.S. Attorney Paul Fishman, declined to comment on the sentence. Nipro bought the company for $215 million in February 2010. Shares of Home Diagnostics, based in Fort Lauderdale, Florida, rose 89 percent after the announcement. The subsidiary, which makes blood glucose monitoring systems and disposable supplies for diabetics, is now known as Nipro Diagnostics.

Read at Bloomberg

Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES